Close Menu

NEW YORK – Rhinostics will license a novel nasal swab from Procter & Gamble and plans to bring it to the clinical laboratory market for SARS-CoV-2 testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.